Description: Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Home Page: www.bellevuespac.com
10900 NE 4th Street
Bellevue,
WA
98004
United States
Phone:
425 635 7700
Officers
| Name | Title |
|---|---|
| Mr. Kuk Hyoun Hwang | CEO & Executive Chairman |
| Mr. David Jin Yoo | Chief Financial Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Financial Services |
| GIC Industry: | Capital Markets |
| GIC Sub-Industry: | Asset Management & Custody Banks |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.0672 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2023-03-17 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |